Text descriptions of graphs on the Gender Equity 2022 Report Card.

Trends over time - NHMRC grant program

Proportion - Woman (CIA)

A vertical bar chart representing the proportion of applications from, and grants and funding awarded to, women lead Chief Investigators in the NHMRC grant program from 2020 to 2022.

  • 44.8% of applications were led by women in 2020.
  • 45.3% of grants were awarded to women in 2020.
  • 42.7% of funding was awarded to women in 2020.
  • 45.6% of applications were led by women in 2021.
  • 46.3% of grants were awarded to women in 2021.
  • 44.4% of funding was awarded to women in 2021.
  • 44.2% of applications were led by women in 2022.
  • 50.0% of grants were awarded to women in 2022.
  • 47.2% of funding was awarded to women in 2022.

Funded Rate (CIA)

Horizontal bar chart representing the funded rate for women and men lead Chief Investigators in the NHMRC grant program from 2020 to 2022.

  • In 2020, the funded rate was 13.0% for women and 12.9% for men.
  • In 2021, the funded rate was 13.4% for women and 13.1% for men.
  • In 2022, the funded rate was 16.9% for women and 13.2% for men.

Schemes

Vertical bar and dot chart representing the funded rate for women and men lead Chief Investigators and the proportion of grants awarded to women by scheme in 2022.

  • For Clinical Trials and Cohort Studies, the funded rate was 11.9% for women and 10.5% for men. The proportion of grants awarded to women was 42.4%.
  • For Centres of Research Excellence, the funded rate was 34.5% for women and 9.1% for men. The proportion of grants awarded to women was 71.4%.
  • For Development Grants, the funded rate was 26.1% for women and 11.5% for men. The proportion of grants awarded to women was 37.5%.
  • For Ideas Grants, the funded rate was 10.9% for women and 11.0% for men. The proportion of grants awarded to women was 41.8%.
  • For Investigator Grants, the funded rate was 17.9% for women and 13.9% for men. The proportion of grants awarded to women was 52.9%.
  • For International Collaborations, the funded rate was 45.5% for women and 56.3% for men. The proportion of grants awarded to women was 52.6%.
  • For Postgraduate Scholarships, the funded rate was 37.9% for women and 36.9% for men. The proportion of grants awarded to women was 58.1%.
  • For Partnership Projects, the funded rate was 37.5% for women and 24.3% for men. The proportion of grants awarded to women was 62.5%.
  • For Synergy Grants, the funded rate was 15.4% for women and 14.0% for men. The proportion of grants awarded to women was 40.0%.
  • For Targeted Calls for Research, the funded rate was 40.0% for women and 20.0% for men. The proportion of grants awarded to women was 78.3%.

Career stage - years post PHD

Horizontal bar chart representing the number of grants and funded rate for women and men lead Chief Investigators in the NHMRC grant program by career stage (years post-PhD) in 2022.

  • For lead Chief Investigators less than 10 years post-PhD, 108 grants were awarded to women at a funded rate of 15.4% and 81 to men at a funded rate of 12.0%.
  • For lead Chief Investigators between 10 and 20 years post-PhD, 109 grants were awarded to women at a funded rate of 15.1% and 99 to men at a funded rate of 12.1%.
  • For lead Chief Investigators more than 20 years post-PhD, 68 grants were awarded to women at a funded rate of 17.4% and 104 to men at a funded rate of 13.3%.

All chief investigators

Horizontal bar chart representing the funded rate for all women and men Chief Investigators in the NHMRC grant program in 2022.

The funded rate was 17.0% for women and 14.4% for men.

Structural priority funding

Vertical bar chart representing the baseline (before structural priority funding) and final funded rates for women and men lead Chief Investigators in relevant schemes in 2022.

  • For Ideas Grants, the baseline funded rate was 7.3% for women and 10.9% for men. The final funded rate was 10.9% for women and 11.0% for men.
  • For Investigator Grant Emerging Leadership category, the baseline funded rate was 13.4% for women and 13.7% for men. The final funded rate was 17.9% for women and 13.9% for men.
  • For Clinical Trials and Cohort Studies, the baseline funded rate was 9.3% for women and 9.9% for men. The final funded rate was 11.9% for women and 10.5% for men.